Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Kogan surges on to New Zealand shores with $122m eCommerce acquisition
    • News

    Kogan surges on to New Zealand shores with $122m eCommerce acquisition

    Following a proven model that skyrocketed Kogan.com (ASX: KGN) to the top of Australia’s eCommerce market, the online retailer is set to follow a similar path in New Zealand with the acquisition of Mighty Ape and its 895,000 subscribers.  A homegrown retailer in New Zealand, Mighty Ape has built a reputation for its quick delivery

    Read More
    Public
  • Summer oysters trial tipped to increase Angel Seafood sales by 15%
    • News

    Summer oysters trial tipped to increase Angel Seafood sales by 15%

    Seafood-loving Australians could soon have access to a wider range of oysters year-round with Angel Seafood (ASX: AS1) set to commence a farming trial of summer oysters which, if successful, would enable them to deliver oysters throughout the calendar year. The trials are part of Angel Seafood’s recently announced 3-pillar growth strategy to double their

    Read More
    Public
  • Are gold prices bottoming out?
    • Opinion

    Are gold prices bottoming out?

    Much has been made of the sell-off in gold across the past month, with analysts pointing to more certain economic conditions. They suggest that gold has fallen due to several promising COVID-19 vaccines and a resolution to the US election. However, gold has shown greater correlation to policy settings rather than economic uncertainty and the

    Read More
    Public
  • Rhythm Biosciences appoint mass manufacturer for bowel cancer test kits
    • News

    Rhythm Biosciences appoint mass manufacturer for bowel cancer test kits

    Aussie medtech company Rhythm Biosciences (ASX: RHY) is set to improve the screening process of colorectal cancer with manufacturing of their ColoSTAT testing kit to commence shortly after having appointed Biotem Limited as their new global manufacturer. Colorectal cancer is the third biggest cause for cancer deaths globally where current screening processes tend only to

    Read More
    Public
  • Feasibility Study confirms Syrah’s lucrative graphite facility in Louisiana
    • News

    Feasibility Study confirms Syrah’s lucrative graphite facility in Louisiana

    Amid the electric vehicle boom and growing desire from US automakers to reduce reliance on China, battery minerals company Syrah Resources (ASX: SYR) has confirmed significantly lower operating costs to supply graphite from their US facility.  The Bankable Feasibility Study (BFS) confirmed the business case for Syrah’s natural graphite Active Anode Material (AAM) production at

    Read More
    Public
  • Genetic Technologies to address mental health with pharmacogenomics AI
    • News

    Genetic Technologies to address mental health with pharmacogenomics AI

    With 1 in 8 Australians suffering from depression, the market for antidepressants is a growing one but one which medical professionals can be assisted to navigate through Genetic Technologies (ASX: GTG) and pharmacogenomics, genomic-based artificial intelligence. The tech will be coming to Australia through a new 3-year distribution agreement with Israel-based Taliaz, the developers of

    Read More
    Public
  • «
  • ‹
  • 548
  • 549
  • 550
  • 551
  • 552
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.